Rhythm

Defibtech Names Robert Reinhardt As New CEO in Executive Shuffle

GUILFORD, Conn.–(BUSINESS WIRE)–Defibtech, LLC, a Nihon Kohden company based in Guilford, Conn., announced today that its board of directors has unanimously chosen Robert Reinhardt as Defibtech’s next chief executive officer. Reinhardt will succeed Gintaras Vaisnys, the company’s co-founder and current CEO, on April 11. Vaisnys will remain as an advisor […]

Biotricity Files for its Second and Final FDA 510(k) to Bring Bioflux Solution to Market

REDWOOD CITY, Calif., April 12, 2017 (GLOBE NEWSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has filed for a second and final 510(k) for the hardware portion of its Bioflux solution with the U.S. Food and Drug Administration […]

Zio by iRhythm Gains Further Recognition as Key Diagnostic Cardiac Monitoring System by US and UK Health Organizations

SAN FRANCISCO, April 10, 2017 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced the recent publication of two documents in support of extended continuous ambulatory monitoring for arrhythmia detection. The American College of Cardiology (ACC), the American […]

Terumo Cardiovascular Group Announces New President and CEO, Robert DeRyke

ANN ARBOR, Mich., April 6, 2017 /PRNewswire/ — Terumo Cardiovascular (CV) Group today announced that Robert (Rob) DeRyke has been appointed President and CEO of Terumo CV Group, effective April 1, 2017, following the retirement of long-time President and CEO Mark Sutter. In this position, DeRyke will lead Terumo’s global business […]

Janssen Collaborates with Premier Inc. on Unique Study to Improve Stroke Risk Management among Hospitalized Patients with Atrial Fibrillation

NEWS PROVIDED BY Janssen Pharmaceuticals, Inc.  | 03 Apr, 2017, 08:00 ET TITUSVILLE, N.J., April 3, 2017 /PRNewswire/ — Janssen Pharmaceuticals, Inc. (Janssen) today announced it has collaborated with Premier Inc. on the first and largest study of its kind to address an unmet medical need for hospitalized patients with atrial fibrillation […]

InfoBionic Names Industry Veteran Stuart Long Chief Executive Officer

BOSTON, April 4, 2017 /PRNewswire/ — InfoBionic (www.infobionic.com) today announced that Stuart Long was named Chief Executive Officer, underscoring the Company’s commitment to widespread market adoption of its transformative wireless remote patient monitoring platform for chronic disease management. “InfoBionic is redefining the ‘standard of care’ for patients and physicians alike with […]

Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation

Press Release DUBLIN – March 30, 2017 – Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP Persistent AF clinical trial. The trial will evaluate the safety and effectiveness of a pulmonary vein isolation-only (PVI) strategy for treating patients with persistent atrial fibrillation (AF), using the Arctic Front Advance(TM) Cardiac […]

New Guidelines Support Use of Cardiac Monitoring for Patients with Unexplained Fainting

Press Release American College of Cardiology, American Heart Association and Heart Rhythm Society Jointly Issue First-Ever Syncope Guidelines that Reinforce Benefits of Continuous Cardiac Monitoring DUBLIN – March 24, 2017 – Newly published guidelines from the American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart Rhythm […]

BIOTRONIK Launches Edora Pacemaker Series with MRI AutoDetect Technology

LAKE OSWEGO, Ore., June 7, 2017 /PRNewswire/ — BIOTRONIK today announced the availability of the Edora line of devices, the company’s first available pacemaker series featuring BIOTRONIK’s MRI AutoDetect technology. Edora SR-T is the smallest MR conditional pacemaker with automated MRI detection capability available in the US with a volume of […]

Aegis Medical Innovations Announces FDA Approval of Clinical Trial

VANCOUVER, British Columbia–(BUSINESS WIRE)–Aegis Medical Innovations Inc. (Aegis) today announced that it has received Investigational Device Exemption approval from the U.S. FDA to initiate a clinical trial in the U.S. for its medical device called the Sierra Ligation System (Sierra). Aegis developed the Sierra technology in partnership with the Mayo […]